HF
VRPX

HRT Financial’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History

HRT Financial’s Portfolio VRPX Stock Details VRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,015
Closed -$9K – 3625
2024
Q4 		$9K Buy
+1,015
New +$13.5K ﹤0.01% 2296

Other funds holding VRPX

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return

HRT Financial's VRPX Position: Q1 2025 in Review

HRT Financial sold out of Virpax Pharmaceuticals, Inc. Common Stock (VRPX) in Q1 2025, closing a stake of 1,015 shares — an estimated $9K sold.

HRT Financial first reported a position in VRPX in Q4 2024 and held it in 1 quarter. The position peaked at $9K in Q4 2024. 7 funds tracked by Wall St. Rank hold VRPX as of Q1 2025.

  • HRT Financial reported no remaining Virpax Pharmaceuticals, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 1,015 Virpax Pharmaceuticals, Inc. Common Stock shares in Q1 2025, an estimated $9K.
  • HRT Financial first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • HRT Financial's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $9K in Q4 2024.
  • 7 funds tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.